Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial

BACKGROUND: Women with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH) experience more frequent and severe angioedema attacks compared with men. Fluctuations in female sex hormones can influence HAE attack frequency and severity. Subcutaneous C1-INH (C1-INH [SC]) is indicated as rou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Clin Immunol
Main Authors: Levy, Donald S., Farkas, Henriette, Riedl, Marc A., Hsu, Florence Ida, Brooks, Joel P., Cicardi, Marco, Feuersenger, Henrike, Pragst, Ingo, Reshef, Avner
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001333/
https://ncbi.nlm.nih.gov/pubmed/32042283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-020-0409-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados